Answers are grounded in this paper and cite their sources.
Cow's milk protein allergy (CMPA) is a genuine cause of morbidity in infancy, yet many complaints attributed to it are also common during normal feeding and gastrointestinal maturation. This narrative and critical review examines how diagnostic elimination is interpreted, why the confirmatory reintroduction step is often omitted, and how these practices contribute to overdiagnosis. PubMed/MEDLINE and the official publications of international allergy and pediatric gastroenterology societies were consulted in 2026, emphasizing challenge-based population studies, observational cohorts, controlled interventions, and guidance published through 2025. Challenge-confirmed allergy is substantially less frequent than parent-reported milk reactions or prescriptions for specialized formula. Symptom improvement during milk avoidance, without reproducible recurrence after reintroduction, provides weak causal evidence because symptoms fluctuate and concurrent interventions are common. The distinction between immediate IgE-mediated reactions, delayed gastrointestinal phenotypes, and ordinary infant behavior determines both the value and safety of diagnostic testing. Short, planned elimination followed by an appropriately supervised or home-based challenge, according to risk, offers a more defensible pathway than an open-ended restrictive diet. Diagnostic precision also protects breastfeeding, nutritional adequacy, family resources, and timely recognition of alternative disease. Clinicians should treat CMPA as a testable hypothesis, not as an explanation automatically assigned to nonspecific infant symptoms.
No takes yet. Share an insight, caveat, or question.
Bastos et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: